545 related articles for article (PubMed ID: 27795301)
1. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
2. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
[TBL] [Abstract][Full Text] [Related]
3. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
4. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
6. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE; Mason PW
Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
[TBL] [Abstract][Full Text] [Related]
7. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
Choi KY; McGregor A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
[TBL] [Abstract][Full Text] [Related]
8. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
9. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
Schleiss MR
J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
[TBL] [Abstract][Full Text] [Related]
10. A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.
Choi KY; Root M; McGregor A
J Virol; 2016 Sep; 90(17):7902-19. PubMed ID: 27334585
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
[TBL] [Abstract][Full Text] [Related]
12. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
Schleiss MR; Bourne N; Bernstein DI
J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
Choi KY; El-Hamdi NS; McGregor A
Vaccine; 2020 Feb; 38(10):2340-2349. PubMed ID: 32008881
[TBL] [Abstract][Full Text] [Related]
14. Congenital Cytomegalovirus: a "Now" Problem-No Really, Now.
Bernstein DI
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795304
[TBL] [Abstract][Full Text] [Related]
15. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
[TBL] [Abstract][Full Text] [Related]
16. Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.
Penaloza MacMaster P; Shields JL; Alayo QA; Cabral C; Jimenez J; Mondesir J; Chandrashekar A; Cabral JM; Lim M; Iampietro MJ; Provine NM; Bricault CA; Seaman M; Orlinger K; Aspoeck A; Fuhrmann G; Lilja AE; Monath T; Mangeat B; Pinschewer DD; Barouch DH
Vaccine; 2017 Jan; 35(1):1-9. PubMed ID: 27899229
[TBL] [Abstract][Full Text] [Related]
17. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
Choi KY; El-Hamdi NS; McGregor A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
[TBL] [Abstract][Full Text] [Related]
18. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
Bernstein DI; Schleiss MR; Berencsi K; Gonczol E; Dickey M; Khoury P; Cadoz M; Meric C; Zahradnik J; Duliege AM; Plotkin S
J Infect Dis; 2002 Mar; 185(5):686-90. PubMed ID: 11865427
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]